Refractory blood pressure in female SHR to increased oxidative stress is not mediated by NO or by upregulation of renal antioxidant enzymes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 2, 2010, Pages

  Lopez Ruiz, Arnaldo F ^a   Iliescu, Radu ^a   Reckelhoff, Jane F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Catalase; F2 isoprostanes; Hypertension; Lucigenin chemiluminescence; Prooxidant; Sexual dimorphism

Indexed keywords

APOCYNIN; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; ISOPROSTANE DERIVATIVE; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME REGULATION; FEMALE; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; FEMALE; HYPERTENSION; ISOPROSTANES; KIDNEY; MALE; MOLSIDOMINE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES; UP-REGULATION; VASODILATOR AGENTS;

EID: 75449097745     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00471.2009     Document Type: Conference Paper

References (18)

1. Berthold H, Munter K, Just A, Kirchheim H, Ehmke H. Stimulation of the renin-angiotensin system by endothelin blockade in conscious dogs. Hypertension 33: 1420-1424, 1999.
2. Chappell M, Westwood B, Yamaleyeva L. Differential effects of sex steroids in young and aged female mREN2. Lewis rats: A model of estrogen and salt-sensitive hypertension. Gender Med 5 Suppl A: S65-S75, 2007.
3. Czernichow S, Bertrais S, Blacher J, Galan p Briancon S, Favier A, Safar M, Hercberg S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU. VI MAX study: association with plasma antioxidant levels. J Hypertens 23: 2013-2018, 2005.
4. Fortepiani LA, Reckelhoff JF. Increasing oxidative stress with molsidomine increases blood pressure in SHR, but not WKY. Am J Physiol Regul Integr Comp Physiol 289: R763-R770, 2005.
5. Fortepiani LA, Reckelhoff JF. Tempol from birth abrogates the sex difference in the depressor response to tempol in SHR. J Hypertens 23: 801-805, 2005.
6. Iliescu R, Yanes LL, Bell W, Dwyer T, Baltatu O, Reckelhoff JF. Role of the renal nerves in control of blood pressure in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 290: R341-R344, 2006.
7. Iliescu R, Cucchiarelli V, Yanes L, Iles J, Reckelhoff J. Impact of androgen-induced oxidative stress on blood pressure in male SHR. Am J Physiol Regul Integr Comp Physiol 292: R731-R735, 2007.
8. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
9. McQueen M, Lonn E, Gerstein H, Bosch J, Yusuf S. The HOPE (Heart Outcomes Prevention Evaluation) study and its consequences. Scand J Clin Lab Invest Suppl 240: 143-156, 2005.
10. Pawlowska D, Granger J, Knox F. Effects of adenosine infusion into the renal interstitium on renal hemodynamics. Am J Physiol Renal Fluid Electrolyte Physiol 252: F678-F682, 1987.
11. Rajagopalan K, Kurz S, Munzel T, Tarpey M, Freeman B, Griendling K, Harrison D. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
12. Reckelhoff J, Zhang H, Srivastava K. Gender differences in the development of hypertension in SHR: Role of the renin-angiotensin system. Hypertension 35: 480-483, 2000.
13. Reckelhoff JF, Kellum J. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci 55: 1895-1902, 1994.
14. Sartori-Valinotti J, Iliescu R, Fortepiani L, Yanes L, Reckelhoff J. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease. Clin Exp Pharm Physiol 34: 938-945, 2007.
15. Sartori-Valinotti J, Iliescu R, Yanes L, Dorsett-Martin W, Reckelhoff J. Sex differences in angiotensin II-induced hypertension: impact of high sodium intake. Hypertension 51: 1170-1176, 2008.
16. Schnackenberg C, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-isoprostaglandin F2α. Hypertension 33: 424-428, 1999.
17. Wilcox CS. Reactive oxygen species : roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
18. Yanes L, Romero D, Iliescu R, Cucchiarelli V, Fortepiani L, Santacruz F, Bell W, Zhang H, Reckelhoff J. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol 288: R229-R233, 2005.